Benign prostatic hypertrophy--measurement of clinical outcomes

Editorial

K M Slawin. J Urol. 1995 Nov.

. 1995 Nov;154(5):1783-4.

doi: 10.1016/s0022-5347(01)66783-1.

No abstract available

Comment on

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, Lepor H. Barry MJ, et al. J Urol. 1995 Nov;154(5):1770-4. doi: 10.1016/s0022-5347(01)66780-6. J Urol. 1995. PMID: 7563343
Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis.
de Wildt MJ, Tubaro A, Höfner K, Carter SS, de la Rosette JJ, Devonec M. de Wildt MJ, et al. J Urol. 1995 Nov;154(5):1775-8. doi: 10.1097/00005392-199511000-00052. J Urol. 1995. PMID: 7563344
The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
Puchner PJ, Miller MI. Puchner PJ, et al. J Urol. 1995 Nov;154(5):1779-82. J Urol. 1995. PMID: 7563345